Cesar Eduardo

Cesar Eduardo has extensive work experience in the medical field, specializing in oncology and hematology. Cesar began their career as a Medical Advisor at PLANINSA in 1998 before transitioning to roles at Eli Lilly and Company, Grupo Ferrer Internacional, and GlaxoSmithKline. At GlaxoSmithKline, they served as an ASCI Medical Scientific Liaison for Latin America, providing therapeutic training and support to clinical teams. Cesar then joined Roche Pharmaceuticals as an Oncology Medical Manager. Cesar Eduardo also had roles at QuintilesIMS as an Associate Medical Director, Parexel as a Medical Director and Senior Medical Director, and most recently at Medpace as a Senior Medical Director. Throughout their career, they have been involved in various medical review activities, protocol development, and scientific advisory roles at different companies.

Cesar Eduardo holds a Master's degree in Molecular Genetics from IVIC, which they obtained from 2000 to 2003. Prior to that, they earned their Medical Doctor degree in Medical from Universidad Central de Venezuela, where they studied from 1994 to 2000. In addition to their degrees, Cesar has also obtained a certification in "Transition from Manager to Leader" from Lynda.com in November 2016. Cesar also holds a board certificate in Molecular Genetics, although information regarding the institution, month, and year of obtaining this certification is not provided.